DenMat Announces Global Distribution of VELscope Vx®

Posted on September 27, 2012


SANTA MARIA, CALIFORNIA, September 26, 2012—DenMat Holdings, LLC (“DenMat has entered into a long-term exclusive agreement with LED Medical Diagnostics, Inc. (“LED”) as the exclusive global distributor (except for a handful of group practices for a limited time) for the VELscope Vx®, including all responsibility for sales and marketing. As the most powerful technology available for assisting in the discovery of oral mucosal abnormalities, VELscope Vx plays a key role in the early discovery of such abnormalities, which can be critically important in the fight against oral cancer.

"We were seeking a partner that not only has a direct relationship with the dental market, but one with the experience and knowledge to bring VELscope Vx to more dentists and their patients," commented Peter Whitehead, LED’s founder and CEO. "DenMat has the experienced team and the proven track record with leading-edge technologies to be our ideal partner in communicating the importance of this powerful system."

VELscope Vx's distinctive blue-spectrum light causes the soft tissues of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns that are visibly disrupted by trauma or disease. Use of the VELscope Vx allows a wide variety of oral abnormalities to be discovered, often before they're visible to the unassisted eye.

"Giving clinicians the power to see potentially life-threatening abnormalities brings a new dimension to patient care, one which we are committed to advancing on a global scale," concluded Mr. Cartagena.

For more information about VELscope Vx visit


© 2015 AEGIS Communications | Privacy Policy